换一批DNA Methylation Classes of Stage II and III Primary Melanomas and Their Clinical and Prognostic Significance.
第一作者：
Kathleen,Conway
第一单位：
Department of Epidemiology, University of North Carolina, Chapel Hill, NC.;Department of Dermatology, University of North Carolina, Chapel Hill, NC.;Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC.
作者：
Kathleen,Conway [1]
;
Sharon N,Edmiston [2]
;
Amanda,Vondras [3]
;
Allison,Reiner [4]
;
David L,Corcoran [5]
;
Ronglai,Shen [4]
;
Eloise A,Parrish [3]
;
Honglin,Hao [6]
;
Lan,Lin [6]
;
Jessica M,Kenney [4]
;
Gbemisola,Ilelaboye [4]
;
Caroline E,Kostrzewa [4]
;
Pei Fen,Kuan [7]
;
Klaus J,Busam [8]
;
Cecilia,Lezcano [8]
;
Tim K,Lee [9]
;
Eva,Hernando [10]
;
Paul B,Googe [11]
;
David W,Ollila [12]
;
Stergios,Moschos [13]
;
Ivan,Gorlov [14]
;
Christopher I,Amos [14]
;
Marc S,Ernstoff [15]
;
Anne E,Cust [16]
;
James S,Wilmott [17]
;
Richard A,Scolyer [18]
;
Graham J,Mann [19]
;
Ismael A,Vergara [20]
;
Jennifer,Ko [21]
;
Judy R,Rees [22]
;
Shaofeng,Yan [23]
;
Eduardo,Nagore [24]
;
Marcus,Bosenberg [25]
;
Bonnie Gould,Rothberg [26]
;
Iman,Osman [10]
;
Jeffrey E,Lee [27]
;
Yvonne,Saenger [28]
;
Paul,Bogner [29]
;
Cheryl L,Thompson [30]
;
Meg,Gerstenblith [31]
;
Sheri L,Holmen [32]
;
Pauline,Funchain [33]
;
Elise,Brunsgaard [34]
;
Natalie D,Depcik-Smith [35]
;
Li,Luo [36]
;
Tawny,Boyce [36]
;
Irene,Orlow [4]
;
Colin B,Begg [4]
;
Marianne,Berwick [36]
;
Nancy E,Thomas [37]
;
InterMEL Study Group
作者单位：
Department of Epidemiology, University of North Carolina, Chapel Hill, NC.;Department of Dermatology, University of North Carolina, Chapel Hill, NC.;Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC.
[1]
Department of Dermatology, University of North Carolina, Chapel Hill, NC.;Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC.;Department of Genetics, University of North Carolina at Chapel Hill, Chapel Hill, NC.
[2]
Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC.
[3]
Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY.
[4]
Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC.;Department of Genetics, University of North Carolina at Chapel Hill, Chapel Hill, NC.
[5]
Department of Dermatology, University of North Carolina, Chapel Hill, NC.
[6]
Department of Applied Mathematics and Statistics, State University of New York, Stony Brook, NY.
[7]
Department of Pathology and Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York, NY.
[8]
British Columbia Cancer Research Center, Vancouver, BC, Canada.
[9]
Grossman School of Medicine, New York University, New York, NY.
[10]
Department of Dermatology, University of North Carolina, Chapel Hill, NC.;Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC.;Department of Pathology and Laboratory Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC.
[11]
Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC.;Department of Surgery, University of North Carolina at Chapel Hill, Chapel Hill, NC.
[12]
Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC.;Division of Oncology, Department of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC.
[13]
Department of Medicine, Baylor Medical Center, Houston, TX.
[14]
ImmunoOncology Branch, National Cancer Institute, Rockville, MD.
[15]
The Daffodil Centre, The University of Sydney, a Joint Venture with Cancer Council NSW, Sydney, NSW, Australia.;Melanoma Institute of Australia, The University of Sydney, Sydney, NSW, Australia.;Sydney School of Public Health, The University of Sydney, Sydney, NSW, Australia.
[16]
Melanoma Institute of Australia, The University of Sydney, Sydney, NSW, Australia.
[17]
Melanoma Institute of Australia, The University of Sydney, Sydney, NSW, Australia.;Faculty of Medicine and Health, The University of Sydney, Sydney, NSW, Australia.;Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital and NSW Health Pathology, Sydney, NSW, Australia.;Charles Perkins Centre, The University of Sydney, Sydney, NSW, Australia.
[18]
Melanoma Institute of Australia, The University of Sydney, Sydney, NSW, Australia.;John Curtin School of Medical Research, Australian National University, Canberra, ACT, Australia.
[19]
Melanoma Institute of Australia, The University of Sydney, Sydney, NSW, Australia.;Faculty of Medicine and Health, The University of Sydney, Sydney, NSW, Australia.;Charles Perkins Centre, The University of Sydney, Sydney, NSW, Australia.
[20]
Cleveland Clinic Foundation, Cleveland, OH.
[21]
Department of Epidemiology, Dartmouth Medical School, Lebanon, NH.
[22]
Department of Pathology and Laboratory Medicine, Dartmouth Hitchcock Medical Center, Lebanon, NH.
[23]
Instituto Valenciano de Oncologia, Valencia, Spain.;Universidad Católica de Valencia San Vicente Mártir, Valencia, Spain.
[24]
Department of Pathology, Yale University, New Haven, CT.
[25]
Leonard Miller School of Medicine, University of Miami, Miami, FL.
[26]
Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX.
[27]
Columbia University Medical School, New York, NY.;Albert Einstein School of Medicine, New York, NY.
[28]
Departments of Pathology and Dermatology, Roswell Park Comprehensive Cancer Center, Buffalo, NY.
[29]
Case Western Reserve University, Cleveland, OH.;Penn State University, Hershey, PA.
[30]
Case Western Reserve University, Cleveland, OH.
[31]
Department of Surgery, University of Utah Health Sciences Center and Huntsman Cancer Institute, Salt Lake City, UT.
[32]
Stanford University, Palo Alto, CA.
[33]
Department of Dermatology, Rush University Medical Center, Chicago, IL.
[34]
GPA Laboratories, Sonic Healthcare, Greensboro, NC.
[35]
Department of Internal Medicine and the UNM Comprehensive Cancer Center, Albuquerque, NM.
[36]
Department of Dermatology, University of North Carolina, Chapel Hill, NC.;Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC.
[37]
医学主题词
人类(Humans);黑色素瘤(Melanoma);DNA甲基化(DNA Methylation);男(雄)性(Male);女(雌)性(Female);中年人(Middle Aged);回顾性研究(Retrospective Studies);皮肤肿瘤(Skin Neoplasms);老年人(Aged);肿瘤分期(Neoplasm Staging);预后(Prognosis);病例对照研究(Case-Control Studies);成年人(Adult);老年人, 80以上(Aged, 80 and over)
DOI
10.1200/PO-24-00375
PMID
39509669
发布时间
2025-11-08
- 浏览0
JCO precision oncology
JCO precision oncology
2024年8卷
e2400375页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文
